Defence Therapeutics applies to use AccuTOX® as an advanced tumour treatment
Defence Therapeutics has submitted an Investigational New Drug application for AccuTOX®, an injectable anticancer molecule.
Familial hypercholesterolaemia identified through genetic testing
Genetic testing can identify patients with familial hypercholesterolaemia to prevent heart attack, stroke, and death.
We must adapt for an ageing population, says Chief Medical Officer
The CMO's new annual report says adapting for an ageing population should be a major aim of policy and medical practice. Read more here.
NHS emergency care continues to experience record demand
New data shows that NHS emergency care had the busiest October on record, with Type 1 attendances facing the busiest month so far this year.
Defence Therapeutics awarded CIPO patent for vaccine technology
Defence Therapeutics has announced that the Canadian Intellectual Property Office (CIPO) has issued a Notice of Allowance for the company's Canadian patent application no....
Our Future Health: UK’s largest health research project reaches one million volunteers
Our Future Health – the largest ever health research programme in the UK – has announced its millionth volunteer has signed up to the project.
Newly discovered gene may trigger treatment-resistant major depressive disorder
In a groundbreaking study, researchers have uncovered a gene that interacts with stress, mediating certain aspects of treatment-resistant major depressive disorder.
Major depressive disorder is...
Combatting bullying in the NHS could save the health service £2.8bn
New research led by the University of Surrey has found that Bullying in the NHS costs the health service £2.8bn each year.
400,000 patients may travel for treatments to cut NHS waiting lists
In a bid to cut NHS waiting lists, hundreds of thousands of patients will be offered the opportunity to travel to different hospitals to...
RECOVERY trial set to investigate revolutionary new flu treatments
The groundbreaking RECOVERY trial, celebrated for its discovery of four effective treatments for COVID-19, is broadening its horizons by venturing into the realm of...
Dementia incidence rate increased in England and Wales after 2008
By studying the dementia incidence rate since 2008, a UCL-led study has found that up to 1.7 million people could be living with dementia...
UK Government announces £5m mental health support hub funding for children
In a significant move aimed at improving the mental well-being of children and young adults, the UK Government has announced an investment of nearly...
AccuTOX® anticancer drug demonstrates exciting antigen cross-presentation
Defence Therapeutics Inc., a prominent Canadian biopharmaceutical company renowned for its work in immune-oncology vaccines and drug delivery technologies, has announced the discovery of...
NHS ADOPT study identifies spine fractures with AI
The NHS ADOPT study has initiated an automated AI process for identifying patients with spine fractures.
Leveraging the power of Artificial Intelligence, the Nanox.AI HealthVCF...
WHO publishes 2023 list of essential in vitro diagnostics
The World Health Organization (WHO) has unveiled its highly-anticipated 2023 Essential Diagnostics List (EDL), a comprehensive catalogue of in vitro diagnostics (IVD) aimed at...
£30m funded PACE initiative announced to combat antimicrobial resistance globally
In a significant collaborative effort to combat antimicrobial resistance, Innovate UK, LifeArc, and Medicines Discovery Catapult (MDC) have combined to launch the £30m funded...
NHS winter vaccination programme breaks flu and COVID-19 jab records
The NHS winter vaccination programme in England has accomplished an extraordinary milestone by delivering more than ten million flu vaccinations and over seven million...
Administration of AccuTOX™-chitosan inhibits the growth of established solid lymphoma in animals
Defence Therapeutics has announced that systemic administration of novel AccuTOX™-chitosan encapsulated formulation inhibits the growth of pre-established solid lymphoma resulting in their progressive shrinking...
NHS successfully deploys 10,000 virtual ward beds
In an impressive achievement, the NHS has realised its ambitious goal of deploying 10,000 virtual ward beds by the close of September, as revealed...
The albumin-to-creatinine ratio: shining a light on early kidney disease
Abbott outlines how albumin-to-creatinine ratio measurement can be leveraged to address the increasing global burden of kidney disease.
Albumin-to-creatinine ratio (ACR) is known to be...
